2019
DOI: 10.23736/s0026-4806.19.06132-9
|View full text |Cite
|
Sign up to set email alerts
|

Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
31
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 38 publications
(34 citation statements)
references
References 69 publications
2
31
0
1
Order By: Relevance
“…Laparoscopy, a minimally invasive approach for debulking surgery, has been widely applied to treat advanced-stage ovarian cancer ( 39 ). A recent case report successfully demonstrated a step-by-step description of the rectosigmoid mesorectal-sparing resection technique performed on a 54-year-old woman with a diagnosis of FIGO stage 3C advanced ovarian cancer ( 40 ).…”
Section: Discussionmentioning
confidence: 99%
“…Laparoscopy, a minimally invasive approach for debulking surgery, has been widely applied to treat advanced-stage ovarian cancer ( 39 ). A recent case report successfully demonstrated a step-by-step description of the rectosigmoid mesorectal-sparing resection technique performed on a 54-year-old woman with a diagnosis of FIGO stage 3C advanced ovarian cancer ( 40 ).…”
Section: Discussionmentioning
confidence: 99%
“…The LANCE (Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy) trial seeks to answer these questions, hypothesizing that for patients who responded to neoadjuvant chemotherapy, minimally invasive interval debulking surgery and laparotomy are equally effective [15]. After all, a systematic re-view by Gueli Alletti et al [16] demonstrated the efficacy and safety of MIS techniques regarding the treatment of advanced ovarian cancer patients and more interestingly the same team suggested that the application of MIS techniques in that very sensitive group of patients plays also a very important role in their psycho-oncologic effect and their quality of life [17]. Furthermore, the INTERNATIONAL MIS-SION study by Fagotti et al [18] as well as a retrospective cohort study by Gallotta et al [19] recently demonstrated that MIS-interval debulking surgery (IDS) can also be an alternative treatment for ovarian cancer patients undergoing secondary cytoreduction following neoadjuvant chemotherapy (NACT).…”
Section: Discussionmentioning
confidence: 99%
“…These include conventional laparoscopy, laparo-endoscopic single-site, robotic multiport, and robotic laparo-endoscopic single-site staging (2)(3)(4)(5). Nowadays, increasing evidence supports the safety of these minimally invasive procedures in ovarian malignancy management (5)(6)(7)(8)(9), suggesting their efficacy even in performing fertilitysparing surgeries or treating advanced stages in carefully selected patients (10,11). The role of minimally invasive surgery in the field of gynecology is continuously evolving thanks to the development of new promising techniques such as robotic and natural orifice transluminal endoscopic surgery (12)(13)(14).…”
Section: Introductionmentioning
confidence: 99%